Items related to Bisphosphonates and Tumor Osteolysis: 116 (Recent Results...
Synopsis
Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz.
"synopsis" may belong to another edition of this title.
Search results for Bisphosphonates and Tumor Osteolysis: 116 (Recent Results...
Stock Image
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research, 116)
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # ABLIING23Mar3113020237540
Quantity: Over 20 available
Seller Image
Bisphosphonates and Tumor Osteolysis
Published by
Springer Berlin Heidelberg Dez 2011, 2011
ISBN 10: 3642836704
ISBN 13: 9783642836701
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz. 92 pp. Englisch. Seller Inventory # 9783642836701
Quantity: 2 available
Seller Image
Bisphosphonates and Tumor Osteolysis
Published by
Springer Berlin Heidelberg, 2011
ISBN 10: 3642836704
ISBN 13: 9783642836701
New
Softcover
Seller: moluna, Greven, Germany
Seller rating 4 out of 5 stars
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism.- Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and Hypercalcemia.- Use of Clodronate and Calcitonin in Hypercalcemia Due to Malignancy.- Treatmen. Seller Inventory # 5071925
Quantity: Over 20 available
Stock Image
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research, 116)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. In. Seller Inventory # ria9783642836701_new
Quantity: Over 20 available
Stock Image
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research)
Published by
Springer Berlin Heidelberg, 2012
ISBN 10: 3642836704
ISBN 13: 9783642836701
New
Paperback
Seller: Revaluation Books, Exeter, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: Brand New. reprint edition. 87 pages. 9.50x6.50x0.30 inches. In Stock. Seller Inventory # x-3642836704
Quantity: 2 available
Seller Image
Bisphosphonates and Tumor Osteolysis
Published by
Springer Berlin Heidelberg, Springer Berlin Heidelberg Dez 2011, 2011
ISBN 10: 3642836704
ISBN 13: 9783642836701
New
Taschenbuch
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 92 pp. Englisch. Seller Inventory # 9783642836701
Quantity: 1 available
Seller Image
Bisphosphonates and Tumor Osteolysis
Published by
Springer Berlin Heidelberg, 2011
ISBN 10: 3642836704
ISBN 13: 9783642836701
New
Taschenbuch
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz. Seller Inventory # 9783642836701
Quantity: 1 available